AU2002218535A8 - Pharmaceutical composition containing an active with a hemolytic action and a surfactant - Google Patents

Pharmaceutical composition containing an active with a hemolytic action and a surfactant

Info

Publication number
AU2002218535A8
AU2002218535A8 AU2002218535A AU2002218535A AU2002218535A8 AU 2002218535 A8 AU2002218535 A8 AU 2002218535A8 AU 2002218535 A AU2002218535 A AU 2002218535A AU 2002218535 A AU2002218535 A AU 2002218535A AU 2002218535 A8 AU2002218535 A8 AU 2002218535A8
Authority
AU
Australia
Prior art keywords
surfactant
active
pharmaceutical composition
composition containing
hemolytic action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2002218535A
Inventor
Kiyoyasu Mizutani
Noburu Negishi
Hirofumi Yamane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Tobacco Inc
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of AU2002218535A8 publication Critical patent/AU2002218535A8/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
AU2002218535A 2000-12-12 2001-12-10 Pharmaceutical composition containing an active with a hemolytic action and a surfactant Withdrawn AU2002218535A8 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000378016 2000-12-12
PCT/JP2001/010809 WO2002047726A2 (en) 2000-12-12 2001-12-10 Pharmaceutical composition containing an active with a hemolytic action and a surfactant

Publications (1)

Publication Number Publication Date
AU2002218535A8 true AU2002218535A8 (en) 2008-01-17

Family

ID=18846659

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002218535A Withdrawn AU2002218535A8 (en) 2000-12-12 2001-12-10 Pharmaceutical composition containing an active with a hemolytic action and a surfactant
AU2002218535A Abandoned AU2002218535A1 (en) 2000-12-12 2001-12-10 Pharmaceutical composition containing an active with a hemolytic action and a surfactant

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2002218535A Abandoned AU2002218535A1 (en) 2000-12-12 2001-12-10 Pharmaceutical composition containing an active with a hemolytic action and a surfactant

Country Status (3)

Country Link
JP (1) JP2002241311A (en)
AU (2) AU2002218535A8 (en)
WO (1) WO2002047726A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10347824B4 (en) * 2003-10-10 2011-08-11 Lach, Hans-Joachim, Dr., 79331 Pharmaceutical or cosmetic composition for the treatment of the skin
JP2012017308A (en) * 2010-07-09 2012-01-26 Nipro Corp Gemcitabine aqueous solution formulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784692A (en) * 1967-06-16 1974-01-08 Warner Lambert Co 17-propionate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
US4318864A (en) * 1979-12-17 1982-03-09 American Cyanamid Company Process for making s-phenenyltris(sulfonylimino)tri-benzene mono- and di-sulfonic acids and salts
JPS60166610A (en) * 1984-02-09 1985-08-29 Fujisawa Pharmaceut Co Ltd Emulsion composition
GB9426104D0 (en) * 1994-12-23 1995-02-22 Merck Sharp & Dohme Use of surfactants and emulsions
JP2829261B2 (en) * 1995-11-02 1998-11-25 日本全薬工業株式会社 Injection for vitamin E and selenium deficiency in livestock
DE69840962D1 (en) * 1997-08-29 2009-08-20 Antigenics Inc ADJUVANT QS-21 CONTAINING COMPOSITIONS WITH POLYSORBATE OR CYCLODEXTRIN AS AID
DE69942708D1 (en) * 1998-02-17 2010-10-07 Schering Corp Virus-containing compositions and methods for the concentration of virus preparations
CN1301154A (en) * 1998-03-26 2001-06-27 日本烟草产业株式会社 Amide derivatives and nociceptin antagonists

Also Published As

Publication number Publication date
WO2002047726A2 (en) 2002-06-20
AU2002218535A1 (en) 2002-06-24
WO2002047726A3 (en) 2007-11-22
JP2002241311A (en) 2002-08-28

Similar Documents

Publication Publication Date Title
HK1046865A1 (en) Particles containing an active ingredient
HUP0302482A3 (en) Novel surfactants and aqueous pesticide formulations
AU2002235128A1 (en) Expression miniarrays and uses thereof
HK1061037A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU6593101A (en) Active substance combinations having insecticidal and acaricidal properties
AU2001265931A1 (en) Active substance combinations having insecticidal and acaricidal properties
AU2002224807A1 (en) Active agent combinations with insecticidal and acaricidal properties
IL151068A0 (en) Active substance combinations comprising insecticidal and acaricidal properties
IL150383A0 (en) Glyburide and pharmaceutical compositions containing the same
AU2001230902A1 (en) Slow-release insect-repellent composition and uses
AU2001233069A1 (en) Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses
EP1364991A4 (en) Semiconductive resion composition and semiconductive member
GB0101035D0 (en) Formulation and use thereof
IL151813A0 (en) Active substance combinations having insecticidal and acaricidal properties
GB0031039D0 (en) Active matrix devices
IL151978A0 (en) Stable and efficacious soft solid product
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AU2002218535A8 (en) Pharmaceutical composition containing an active with a hemolytic action and a surfactant
HUP0301119A3 (en) Biologically active agent and drug
AU2001262699A1 (en) Biologically active agents and drugs
MXPA03002900A (en) New pharmaceutical compositions containing epinastine and pseudoephedrine.
GB0007850D0 (en) Passive and active protection against mycobacterial infections
AU2001231769A1 (en) 1-o-l-arginyl ester 3-o-monoacyl glycerides and 1-o-l-arginyl ester 2,3-o-diacylglycerides type surface active agents
GB0010218D0 (en) Active picture in picture
AU2002228109A1 (en) Repellent cosmetic composition active against schistosome furcocercaria

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase